JawSpace V2:

The future of TMD self-management is coming

A new era in TMD self-management—launching soon.

Following the success of JawSpace V1—and shaped by valuable feedback from both users and clinicians—we’re proud to announce the upcoming release of JawSpace V2, our most comprehensive update yet.

Developed in collaboration with researchers and clinicians from Newcastle University, V2 builds on everything our community loved, while introducing deeper tailoring, a redesigned experience, and expanded support tools for people living with Temporomandibular Disorders (TMD).

Grounded in current research and best-practice principles for conservative TMD care, V2 offers improved structure, clearer guidance, and a more intuitive way to integrate evidence-informed self-care into everyday life.

To ensure safe and appropriate use across regions, JawSpace V2 will be released in two versions:

Lifestyle version (Non-medical device)

Launching globally, the lifestyle version includes features such as guided routines, symptom logging, and self-care resources. It is suitable for individuals who wish to better understand and manage their jaw-related symptoms through evidence-informed self-management strategies.

Available worldwide from late April 2025.

Medical device version (SaMD)

The medical version of JawSpace is being developed as a regulated Software as a Medical Device (SaMD). It will include a guided self-assessment designed to help users reflect on their symptoms, and a structured self-management plan aligned with internationally recognised principles of conservative care for TMD.

Planned regional rollout:

• 🇦🇺 Australia – TGA submission (April 2025)

• 🇬🇧 United Kingdom – MHRA registration (May 2025)

• 🇺🇸 United States – FDA submission (mid–2025)

• 🇪🇺 Europe – CE marking to follow

The lifestyle version will remain accessible where the medical version is not yet available.

What’s new in V2?

1. A more tailored experience (medical device version only)

• A guided self-assessment to help users better understand their symptoms

• Self-management plans tailored to users' responses, grounded in current best-practice principles

2. New Content Library & Guided Tools

• Explore an expanded library of evidence-informed content designed to support self-management and build daily routines with confidence.

• Educational resources on TMD symptoms including persistent TMD and pain science

• New guided jaw exercises: mobility, strengthening, and relaxation

• Step-by-step guidance for thermal therapies and self-massage

• Breathing, visualisation, and calming techniques to help regulate tension and stress

3. Expanded symptom tracking & insights

• Daily check-ins to log symptoms such as jaw discomfort, clenching, and sleep quality

• Trends and insights to support self-awareness over time

4. On-demand relief tools

• The JawSpace Relief Kit offers quick-access strategies to support symptom management during flare-ups

5. Routine support

• Smart reminders to help users stay consistent with their care routines

• Tools designed to support long-term habit formation

6. Redesigned user interface

• We've reimagined the JawSpace experience with a fresh, intuitive interface—making it easier than ever to log symptoms, follow routines, and explore content.

7. Now with audio accessibility

• Thanks to Speechify’s API integration, users can now listen to written content across the app—perfect for on-the-go learning or accessible support when reading feels difficult.

Regulatory disclaimer

JawSpace V2 is currently available as a lifestyle application and is not a substitute for professional medical advice, diagnosis, or treatment. The lifestyle version is not intended to diagnose, treat, cure, or prevent any disease or medical condition.

The medical device version of JawSpace is in development and has not yet been submitted to or approved by the Therapeutic Goods Administration (TGA) in Australia, the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom, the U.S. Food and Drug Administration (FDA), or granted CE marking for use in the European Union.

Until regulatory approvals are obtained, only the non-medical, lifestyle version of the app will be made available for general use. Users should consult a qualified healthcare professional for advice relating to TMD or any medical condition.